Involvement of IL-17 in Fas ligand-induced inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Involvement of IL-17 in Fas ligand-induced inflammation

Published:2004-07-05 Issue:8 Volume:16 Page:1099-1108
ISSN:1460-2377
Container-title:International Immunology
language:en
Short-container-title:

Author:

Umemura Masayuki,Kawabe Takaya,Shudo Koyo,Kidoya Hiroyasu,Fukui Masayuki,Asano Masahide,Iwakura Yoichiro,Matsuzaki Goro,Imamura Ryu,Suda Takashi

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/16/8/1099/17412973/dxh111.pdf

Reference47 articles.

1. Nagata, S. and Suda, T. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today16:39.

2. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. and Ferguson, T. A. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science270:1189.

3. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. and Duke, R. C. 1995. A role for CD95 ligand in preventing graft rejection. Nature377:630.

4. O'Connell, J., O'Sullivan, G. C., Collins, J. K. and Shanahan, F. 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med.184:1075.

5. Seino, K., Kayagaki, N., Okumura, K. and Yagita, H. 1997. Antitumor effect of locally produced CD95 ligand. Nat. Med.3:165.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of N‐Glycosylated Soluble Fas Ligand;Chemistry – A European Journal;2024-03-07

2. Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials;Current Opinion in Pharmacology;2022-12

3. Two functionally distinct subsets of IL‐17 producing γδ T cells;Immunological Reviews;2020-07-22

4. Inflammation-induced DNA damage, mutations and cancer;DNA Repair;2019-11

5. The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations;OncoImmunology;2019-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3